Company

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries — Israeli pharmaceutical company. Ticker: NYSE: TEVA. Every TV10 Global story that covers or mentions Teva Pharmaceutical Industries, translated into English from TV10's Hebrew reporting.

Type
Company
Ticker
NYSE: TEVA

17 stories on TV10 Global

The Tel Aviv Stock Exchange
Opening the Week

Mixed Trend at Start of Trading Week as Dual-Listed Stocks Weigh

The October CPI fell 0.1%, again raising the possibility of an interest rate cut as soon as next week • Negative gaps in chip stocks weighed on the opening • Bank Hapoalim will distribute more than NIS 1 billion, and Isracard will lay off about 350 employees

TV10 Desk
The Tel Aviv Stock Exchange
Earnings Season Continues

TASE Trading Week: Dual-Listed Stocks Signal Lower Open

Tower is expected to plunge more than 7%, while Nova and Camtek are each expected to lose more than 3% • In contrast, Teva and NICE may stand out positively • Earnings season continues: Leumi, Discount and Elbit Systems will report results this week

TV10 Desk
The Tel Aviv Stock Exchange
Breaking

Tel Aviv stocks close higher, led by banks and insurers

The TA-35 rose 2.2% to 4,101 points, and the TA-90 added 1.6% • Bank Leumi and Bank Hapoalim shares stood out with high trading volumes, Next Vision surged 6.8%, and OPC rose after reporting a 120% jump in profit • Gilat, meanwhile, plunged 18.2% after lowering its forecasts

TV10 Desk
Liran Ben Horin
Breaking

Will Liran Avishar Ben-Horin Chair the Finance Committee?

Former Communications Ministry Director-General Liran Avishar Ben-Horin of Naftali Bennett's Beyachad party is the change bloc's candidate to chair the Finance Committee • Her husband, Itay Ben-Horin, owns 50% of the Ben Horin Alexandrovitz public relations firm, whose clients include Mizrahi-Tefahot, Fox, Strauss and Teva • Another conflict of interest concerns her role and the issues she handled until recently as a senior executive at the Keystone Infrastructure Fund, which controls Egged and HOT Mobile, among other companies

Sharon Birkman
The Tel Aviv Stock Exchange
Breaking

Moderate gains on TASE; chip stocks drag lower

Trading in Tel Aviv opened with modest gains, against the backdrop of gains in global markets, but chip stocks stand out with declines of more than 4% and weigh on the indexes • Tower Semiconductor and Camtek lead the declines, while Palo Alto Networks also weakens • Teva may ease the pressure. Meanwhile, U.S. energy giant Murphy Oil is entering Israel for the first time and will cooperate with Ratio Energies on offshore gas exploration

TV10 Desk
Teva Pharmaceutical Industries
Breaking

Teva Executives Sold Shares Worth About $3 Million

The interim chief legal officer and a senior vice president for international markets sold more than 72,000 shares of the pharmaceutical company, worth a combined total of about $3.02 million • The sales were reported to the U.S. Securities and Exchange Commission (SEC)

TV10 Desk
The Tel Aviv Stock Exchange
Volatile Trading

TASE Closes Mixed: Which Stock Surged About 34%?

TA-90 fell 0.96%, while TA-35 added about 0.29% • Aura Smart stock plunged about 30% • The euro rose about 0.45% to NIS 3.52, while the dollar traded at NIS 3.16

Shai Nogai
Teva stock
Above expectations

Teva Reports Revenue of $4.4 Billion

Adjusted gross profit margin soared to a decade high of 58.7% • The company raised its annual revenue forecast following sharp growth in innovative medicines

Shai Nogai
The Tel Aviv Stock Exchange
Breaking

TASE Continues to Fall; Sofwave Stock Jumps 9%

Tel Aviv indices open lower for a third consecutive trading day amid earnings season • Sofwave stands out following its third-quarter results, Amot reports moderate NOI growth, and Teva is set to publish its results later today

TV10 Desk
The Tel Aviv Stock Exchange
Breaking

Volatile TASE trading: Perion surges about 30%, Gene Technology rises 7%

Leading indexes trade steadily with a slight upward bias • Perion surges following an agreement to sell it to India’s Affle for about $420 million, while Gene Technology climbs about 7% • Gab-Yam opens the local earnings season with a 68% jump in net profit • Tower, Teva and Camtek are among the companies reporting this week

TV10 Desk
The Tel Aviv Stock Exchange
Breaking

Tel Aviv Earnings Season: Teva, El Al and Tower in Focus This Week

After a month of declines in the Tel Aviv and New York markets, the coming trading week will mark the start of earnings season in Israel and a series of reports from Wall Street giants, including Apple, AMD and Palantir • In the background: concerns over the scale of artificial intelligence investment and the possibility of continued market volatility

TV10 Desk
The Tel Aviv Stock Exchange
Breaking

TASE index update: Stocks joining TA-35 — and those leaving

El Al and Doral are expected to join the flagship index, while Y.H. Dimri, Shufersal and Kenon will move to TA-90 • 15 companies that went public this year are expected to enter the indices, technology’s weight in TA-35 will rise to 32.2%, and trading turnover on the update day may reach NIS 18 billion

TV10 Desk
The Tel Aviv Stock Exchange
Breaking

TASE Recovers Slightly, Insurance Stocks Fall 2.4%

TA-35 rose 0.3% and TA-125 added 0.1% after a volatile trading day, following yesterday’s sharp declines amid interim election results • TA-Banks gained 0.7%, the energy index rose 1.2%, and Palo Alto plunged 6.5% following rival Fortinet’s earnings report

TV10 Desk
Teva stock
Hit a Record High

FDA Approves New Teva Schizophrenia Treatment — Stock Jumps

Teva received approval from the U.S. Food and Drug Administration to market WELTRUZA, intended for adults • The new treatment is based on the active ingredient olanzapine and is administered as a once-monthly subcutaneous injection without the need for loading doses • The drug is expected to be available in the United States in the coming weeks

TV10 Editorial Staff
Palo Alto Networks
Unprecedented

History on TASE: Palo Alto Crosses NIS 1 Trillion Valuation

The cybersecurity company’s stock surged 5.48% on Thursday and reached an all-time high on the local exchange • Its new valuation puts it far ahead of the next company on the list, Teva, which trades at a valuation of about NIS 143 billion • The trading day itself ended mixed, with turnover of about NIS 3.2 billion

TV10 Editorial Staff
Teva stock
Upgrade

Turnaround Complete: Teva Regains Investment-Grade Rating From All Agencies

S&P upgraded Teva’s long-term credit rating from BB+ to BBB- with a stable outlook • The move completes the company’s return to investment grade at all three major rating agencies after several years • The company says the upgrade reflects growth in innovative medicines and stabilization in generics

TV10 Editorial Staff